title: Identification of serum sirtuins as novel noninvasive protein markers for frailty.
abstract: Frailty has emerged as a major health issue among older patients. A consensus on definition and diagnosis is yet to be achieved. Various biochemical abnormalities have been reported in frailty. Activation of sirtuins, a conserved family of NAD-dependent proteins, is one of the many mimics of calorie restriction which improves lifespan and health in experimental animals. In this cross-sectional study, we assessed the circulating sirtuin levels in 119 (59.5%) nonfrail and 81 (40.5%) frail individuals, diagnosed by Fried's criteria. Serum SIRT1, SIRT2, and SIRT3 were estimated by surface plasmon resonance (SPR) and Western blot. Serum sirtuins level in mean+SD; SIRT1 (nonfrail -4.67 ± 0.48 ng/μL; frail - 3.72 ± 0.48 ng/μL; P < 0.0001), SIRT2 (nonfrail - 15.18 ± 2.94 ng/μL; frail - 14.19 ± 2.66 ng/μL; P = 0.016), and SIRT3 (nonfrail-7.72 ± 1.84 ng/μL; frail - 6.12 ± 0.97 ng/μL; P < 0.0001) levels were significantly lower among frail patients compared with the nonfrail. In multivariable regression analysis, lower sirtuins level were significantly associated with frailty after adjusting age, gender, diabetes mellitus, hypertension, cognitive status (Mini Mental State Examination scores) and number of comorbidities. For detecting the optimum diagnostic cutoff value a ROC analysis was carried out. The area under curve for SIRT1 was 0.9037 (cutoff - 4.29 ng/μL; sensitivity - 81.48%; specificity - 79.83%) and SIRT3 was 0.7988 (cutoff - 6.61 ng/μL; sensitivity - 70.37%; specificity - 70.59%). This study shows that lower circulating SIRT1 and SIRT3 levels can be distinctive marker of frailty.
authors.affiliation: Department of Biophysics, All India Institute of Medical Sciences, New Delhi, 110029, India.
authors.forename: Rahul
authors.initials: R
authors.lastname: Kumar
authors.forename: Navinath
authors.initials: N
authors.lastname: Mohan
authors.forename: Ashish Datt
authors.initials: AD
authors.lastname: Upadhyay
authors.forename: Amrendra Pratap
authors.initials: AP
authors.lastname: Singh
authors.forename: Vishal
authors.initials: V
authors.lastname: Sahu
authors.forename: Sadanand
authors.initials: S
authors.lastname: Dwivedi
authors.forename: Aparajit B
authors.initials: AB
authors.lastname: Dey
authors.forename: Sharmistha
authors.initials: S
authors.lastname: Dey
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D015415:Biomarkers / Q000097:blood*; D005260:Female; D016330:Frail Elderly; D006801:Humans; D008297:Male; D037761:Sirtuins / Q000097:blood*; D020349:Surface Plasmon Resonance
chemical_list: D015415:Biomarkers; D037761:Sirtuins
keywords: biomarker; frailty; serum; sirtuin; surface plasmon resonance
references.citation: Cell. 2008 Jul 25;134(2):329-40
references.pmid: 18662547
references.citation: J Am Geriatr Soc. 2009 Sep;57(9):1666-71
references.pmid: 19682113
references.citation: J Am Geriatr Soc. 2007 Jun;55(6):864-71
references.pmid: 17537086
references.citation: J Gerontol A Biol Sci Med Sci. 2006 Mar;61(3):278-83
references.pmid: 16567378
references.citation: J Am Geriatr Soc. 1993 Sep;41(9):1004-8
references.pmid: 8409170
references.citation: J Gerontol A Biol Sci Med Sci. 2011 Jan;66(1):3-8
references.pmid: 20819794
references.citation: Genes Dev. 2006 Nov 1;20(21):2913-21
references.pmid: 17079682
references.citation: Mol Cell. 2007 Oct 12;28(1):91-106
references.pmid: 17936707
references.citation: Genes Dev. 1999 Oct 1;13(19):2570-80
references.pmid: 10521401
references.citation: J Cell Sci. 2011 Mar 15;124(Pt 6):833-8
references.pmid: 21378304
references.citation: Nature. 2010 Mar 25;464(7288):503
references.pmid: 20336131
references.citation: J Gerontol A Biol Sci Med Sci. 2001 Mar;56(3):M146-56
references.pmid: 11253156
references.citation: Nat Commun. 2010 Apr 12;1:3
references.pmid: 20975665
references.citation: Endocr Metab Immune Disord Drug Targets. 2010 Mar;10(1):16-24
references.pmid: 20044906
references.citation: Lancet. 2013 Mar 2;381(9868):752-62
references.pmid: 23395245
references.citation: Mol Cell Proteomics. 2002 Nov;1(11):845-67
references.pmid: 12488461
references.citation: JAMA. 1992 Apr 1;267(13):1806-9
references.pmid: 1482430
references.citation: Exp Gerontol. 2009 Aug;44(8):511-6
references.pmid: 19457449
references.citation: J Am Geriatr Soc. 2002 Jul;50(7):1268-71
references.pmid: 12133023
references.citation: Proc Natl Acad Sci U S A. 2004 Nov 9;101(45):15998-6003
references.pmid: 15520384
references.citation: Annu Rev Nutr. 2002;22:309-23
references.pmid: 12055348
references.citation: EMBO J. 2004 Jun 16;23(12):2369-80
references.pmid: 15152190
references.citation: Proteomics. 2005 Aug;5(12):3019-34
references.pmid: 16041673
references.citation: Nature. 2000 Feb 17;403(6771):795-800
references.pmid: 10693811
references.citation: Cell Rep. 2014 Mar 13;6(5):836-43
references.pmid: 24582957
references.citation: J Am Geriatr Soc. 2005 Jun;53(6):1069-70
references.pmid: 15935037
references.citation: N Engl J Med. 2011 Jun 9;364(23):2235-44
references.pmid: 21651395
references.citation: Aging Clin Exp Res. 2004 Apr;16(2):153-7
references.pmid: 15195991
references.citation: Nature. 2001 Mar 8;410(6825):227-30
references.pmid: 11242085
references.citation: Br J Anaesth. 1969 Mar;41(3):227-34
references.pmid: 5776667
references.citation: J Gerontol A Biol Sci Med Sci. 2013 Sep;68(9):1112-21
references.pmid: 23657973
references.citation: PLoS One. 2013 Apr 16;8(4):e61560
references.pmid: 23613875